Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA clears CTI's PET (positron emission tomography) scanner:

This article was originally published in Clinica

Executive Summary

CTI has received US FDA 510k(k) clearance for its ECAT ACCEL PET scanner, which the company claims can provide better resolution than current PET scanners and reduce scanning time from 40 to 20 minutes. The device uses a new detector crystal, lutetium oxyortho-silicate, which Knoxville, Tennessee-based CTI says has high-energy imaging characteristics that enable doctors to monitor precisely the efficacy and side effects of chemotherapy drugs and improve patient throughput while maintaining image quality.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT075360

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel